对认知障碍的适应性系统:对当前趋势和未来方向的系统审查
Noor Alakkas1,2, Sajjad Mahmood1,3
1Information and Computer Science Department, King Fahd University of Petroleum and Minerals, Dhahran, Saudi Arabia.
Disability and rehabilitation. Assistive technology
|March 4, 2026
概括
适应性系统为认知障碍者提供个性化的信息和通信技术 (ICT). 目前的研究重点是针对儿童的教育网络应用程序,但缺乏反循环和大规模评估.
科学领域:
- 人与计算机的交互
- 辅助技术 辅助技术 辅助技术
- 认知科学 认知科学
背景情况:
- 认知障碍对包容性信息和通信技术 (ICT) 设计提出了重大挑战.
- 适应性系统提供针对个人的认知能力量身定制的个性化ICT解决方案.
研究的目的:
- 对认知障碍用户的适应性系统的现状进行审查.
- 确定这一领域的趋势,差距和未来的研究方向.
主要方法:
- 按照PRISMA指南进行的系统文献审查 (SLR).
- 71项初级研究的选择和质量评估.
主要成果:
- 最近的重点是针对轻度神经发育障碍儿童的教育网络应用程序.
- 利用以用户为中心和以模型为导向的方法,遵守Web内容可访问性指南.
- 基于规则的技术和图形/行为调整的普及,对反循环的有限使用.
- 评估往往缺乏从目标人群中获得足够数量的参与者.
结论:
- 为认知障碍患者设计有效和包容的适应性系统提供了洞察力.
- 突出了重要的设计考虑和未充分探索的研究领域.
相关概念视频
Cognitive Enhancers: Cholinesterase Inhibitors and NMDA Receptor Antagonists
765
Cognitive enhancers, also known as "smart drugs," are substances used to enhance memory, mental alertness, and concentration. These can be natural or synthetic and improve cognition in conditions like Alzheimer's disease (AD) and other neurodegenerative diseases. Some common examples include caffeine, amphetamines, methylphenidate, modafinil, arecoline, donepezil, vortioxetine, and piracetam. These enhancers work on the principle of synaptic plasticity and altered circuit function.
765
Cognitive Development During Adulthood
1.0K
Cognitive development continues throughout adulthood, undergoing significant shifts across early, middle, and late stages. Individual transition occurs from adolescent idealism to pragmatic and adaptable thinking in early adulthood. During this period, individuals learn to integrate personal beliefs with the recognition that other perspectives are equally valid. Exposure to the complexities of modern society, diverse experiences, and higher education contribute to this adaptive thought process,...
1.0K
Alzheimer's Disease: Treatment
1.1K
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
1.1K
Alzheimer's Disease: Overview
1.9K
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
1.9K
Information Processing Approach
676
The information-processing theory of cognitive development centers on fundamental mental processes, including attention, memory, and problem-solving skills. Researchers in this field examine how cognitive abilities, such as working memory, evolve and influence children's overall development. Studies indicate that children with stronger working memory tend to excel in reading comprehension, math, and problem-solving compared to peers with less efficient memory skills. Low working memory is...
676


